For me this stock is easy to hold with significant catalysts in the near future.. (i.e. revenue guidance, lympro data).. and we all know this stock runs "into" conferences.. and we have three of those coming up. Throw in the wildcard (potential spin-off) and imo it is a pretty good bet with the share price having consolidated at these levels. People fear a rs.. but I have to give gc and the board some credit in common sense.. imo it makes NO sense to implement a rs without strength. Good luck to all longs!